156 related articles for article (PubMed ID: 27488298)
1. Clinical Decision Making: Integrating Advances in the Molecular Understanding of Spine Tumors.
Goodwin CR; Abu-Bonsrah N; Bilsky MH; Reynolds JJ; Rhines LD; Laufer I; Disch AC; Bozsodi A; Patel SR; Gokaslan ZL; Sciubba DM; Bettegowda C
Spine (Phila Pa 1976); 2016 Oct; 41 Suppl 20():S171-S177. PubMed ID: 27488298
[TBL] [Abstract][Full Text] [Related]
2. Molecular Markers and Targeted Therapeutics in Metastatic Tumors of the Spine: Changing the Treatment Paradigms.
Goodwin CR; Abu-Bonsrah N; Rhines LD; Verlaan JJ; Bilsky MH; Laufer I; Boriani S; Sciubba DM; Bettegowda C
Spine (Phila Pa 1976); 2016 Oct; 41 Suppl 20():S218-S223. PubMed ID: 27488299
[TBL] [Abstract][Full Text] [Related]
3. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
4. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
5. Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of Immunotherapy.
Grivas P; Yu EY
Curr Treat Options Oncol; 2019 Jun; 20(8):67. PubMed ID: 31254108
[TBL] [Abstract][Full Text] [Related]
6. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
7. Primary osseous tumors of the pediatric spinal column: review of pathology and surgical decision making.
Ravindra VM; Eli IM; Schmidt MH; Brockmeyer DL
Neurosurg Focus; 2016 Aug; 41(2):E3. PubMed ID: 27476845
[TBL] [Abstract][Full Text] [Related]
8. Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges.
Chan JY; Choudhury Y; Tan MH
Expert Rev Mol Diagn; 2015 May; 15(5):631-46. PubMed ID: 25837857
[TBL] [Abstract][Full Text] [Related]
9. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer Biomarkers: Current Status.
Hodges KB; Bachert E; Cheng L
Crit Rev Oncog; 2017; 22(5-6):253-269. PubMed ID: 29604917
[TBL] [Abstract][Full Text] [Related]
11. State of the art management in spine oncology: a worldwide perspective on its evolution, current state, and future.
Sundaresan N; Boriani S; Okuno S
Spine (Phila Pa 1976); 2009 Oct; 34(22 Suppl):S7-20. PubMed ID: 19816243
[TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.
Levy B; Hu ZI; Cordova KN; Close S; Lee K; Becker D
Oncologist; 2016 Sep; 21(9):1121-30. PubMed ID: 27388233
[TBL] [Abstract][Full Text] [Related]
13. Cancer biomarker discovery and translation: proteomics and beyond.
Hristova VA; Chan DW
Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
[TBL] [Abstract][Full Text] [Related]
14. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
Willems P
Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment of metastatic spine tumors: the future is not what it used to be.
Laufer I; Bilsky MH
J Neurosurg Spine; 2019 Mar; 30(3):299-307. PubMed ID: 30835704
[TBL] [Abstract][Full Text] [Related]
16. Emerging and established clinical, histopathological and molecular parametric prognostic factors for metastatic spine disease secondary to lung cancer: Helping surgeons make decisions.
Batista N; Tee J; Sciubba D; Sahgal A; Laufer I; Weber M; Gokaslan Z; Rhines L; Fehlings M; Patel S; Raja Rampersaud Y; Reynolds J; Chou D; Bettegowda C; Clarke M; Fisher C
J Clin Neurosci; 2016 Dec; 34():15-22. PubMed ID: 27634496
[TBL] [Abstract][Full Text] [Related]
17. Precision medicine for metastatic colorectal cancer: an evolving era.
Guler I; Askan G; Klostergaard J; Sahin IH
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):919-931. PubMed ID: 31475851
[No Abstract] [Full Text] [Related]
18. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer: Molecular markers and management of advanced stage disease.
Arend RC; Jones BA; Martinez A; Goodfellow P
Gynecol Oncol; 2018 Sep; 150(3):569-580. PubMed ID: 29843906
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
